KD Market
Insights has
published a new report on DNA sequencing Market analysis and forecast 2018-2025. The
report comprises of DNA sequencing Market size, Y-o-Y growth analysis, and
market dynamics, including growth drivers, restraining factors, opportunities,
and trends which are spearheading current nature and future status of the
market.
DNA sequencing is a molecular technique that helps determine the
nucleotide sequence of DNA (deoxyribonucleic acid), which is the most
fundamental level of knowledge of a gene or genome. The global DNA
sequencing market accounted for $6,243 million in 2017, and is anticipated
to reach $25,470 million by 2025, registering a CAGR of 19.0% from
2017 to 2025. DNA sequencing has revolutionized molecular biology and genomics
research. The knowledge of DNA sequences of genes and other parts of the genome
of organisms has become essential for life-science research and also in applied
fields, such as forensics, cancer diagnostics, and others. Through this method,
billions of DNA strands can be sequenced efficiently. DNA sequencing has made
it possible to conveniently sequence whole genomes and analyze various
DNA-protein interactions. This technique allows the researcher to focus, study,
and interpret deep sequence target regions. They are utilized through varied
interventions, such as oncology, biomarker studies, drug discovery,
understanding reproductive health, and personalized genomics.
Technological advancements in sequencing equipment, surge in applications of DNA sequencing, and increase in genome mapping programs drive the global DNA sequencing market. In addition, rise in awareness pertaining to DNA sequencing and increase in investment in research, development, and innovation supplement the market growth. However, lack of skilled professionals, ethical & legal limitations related to DNA sequencing, and standardization concerns in sequencing procedures impede the market growth. Furthermore, use of cloud computing as a potential data management service and the untapped emerging countries offer lucrative opportunities for the market players.
The DNA sequencing market is
segmented based on product, application, technology, end user, and geography.
Based on product, it is categorized into consumable, instrument, and service.
The consumables segment accounted for a dominant share in 2017 and is expected
to maintain this trend during the forecast period. This is attributed to the
fact that they are widely used throughout the sample preparation process and
other pre-requisite steps of DNA sequencing.
Based on application, it is categorized into
biomarkers & cancer, diagnostics, reproductive health, personalized
medicine, forensics, and other applications. The biomarkers & cancer
application was the highest revenue contributor in 2017, while the personalized
medicine segment is anticipated to grow at the highest rate. The growth for
this segment is due to increase in investment in R&D globally and surge in
awareness about DNA sequencing applications in precision medicine. Based on
technology, the DNA sequencing technology market is classified into sequencing
by synthesis, ion semiconductor sequencing, sequencing by ligation,
pyrosequencing, single molecule real-time sequencing, chain termination
sequencing, and nanopore sequencing technologies. The sequencing by synthesis technology
segment accounted for the highest share in 2017 and is estimated to continue
this trend throughout the study period as this technology allows both short and
long insert paired end reads for high resolution genome sequencing, structural
variation detection, sequence assembly, and others.
Based on region, this market is analyzed
across North America, Europe, Asia-Pacific, and LAMEA. North America accounted
for the highest market share in the DNA sequencing market in 2017 and is
expected to maintain its dominance throughout the forecast period. This is
primarily attributed to the higher buying power, availability, and applications
that favor the utilization of DNA sequencing. There is also an increase in
agreements and collaborations between different market players and health
centers to promote and utilize DNA sequencing in this region. However,
Asia-Pacific is expected to emerge as a lucrative area with maximum growth
potential, owing to the improvement in R&D facilities, rise in disposable
income, and rapidly development in economic conditions.
- The study provides an in-depth analysis of
the global DNA sequencing market and the current trends and future estimations
to elucidate the imminent investment pockets.
- The report presents quantitative analysis of the market from 2017 to 2025 to enable the stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the market based on product assists to understand the trends in the industry.
- Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the industry
- The report presents quantitative analysis of the market from 2017 to 2025 to enable the stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the market based on product assists to understand the trends in the industry.
- Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the industry
Key DNA sequencing Market:
By Product
- Consumable
- Instrument
- Service
- Instrument
- Service
By Application
- Diagnostics
- Biomarkers and Cancer
- Reproductive Health
- Personalized Medicine
- Forensics
- Other Applications
- Biomarkers and Cancer
- Reproductive Health
- Personalized Medicine
- Forensics
- Other Applications
By Technology
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Sequencing by Ligation
- Pyrosequencing
- Single Molecule Real-Time Sequencing
- Chain Termination Sequencing
- Nanopore Sequencing
- Ion Semiconductor Sequencing
- Sequencing by Ligation
- Pyrosequencing
- Single Molecule Real-Time Sequencing
- Chain Termination Sequencing
- Nanopore Sequencing
By End User
- Academic & Government Research
Institutes
- Pharmaceutical Companies
- Biotechnology Companies
- Hospitals & Clinics
- Pharmaceutical Companies
- Biotechnology Companies
- Hospitals & Clinics
By Region
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan
- Rest of Asia-Pacific
LAMEA
- Brazil
- Turkey
- Saudi Arabia
- Rest of LAMEA
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan
- Rest of Asia-Pacific
LAMEA
- Brazil
- Turkey
- Saudi Arabia
- Rest of LAMEA
List of Key Players Profiled in the Report
- Abbott Laboratories
- Agilent Technologies, Inc.
- Danaher Corporation (Beckman Coulter, Inc.)
- F. Hoffmann-La Roche Ltd
- Illumina, Inc
- LI-COR Biosciences, Inc.
- Pacific Biosciences of California, Inc.
- SIEMENS AG; PerkinElmer Inc.
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- Danaher Corporation (Beckman Coulter, Inc.)
- F. Hoffmann-La Roche Ltd
- Illumina, Inc
- LI-COR Biosciences, Inc.
- Pacific Biosciences of California, Inc.
- SIEMENS AG; PerkinElmer Inc.
- Thermo Fisher Scientific, Inc.
Table of Content
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top winning strategies
3.4. Market share analysis
3.4. Market share analysis
3.4.1. Overview
3.5. Patents analysis
3.5.1. Patent analysis, by region
3.5.2. Patent analysis, by year
3.5.2. Patent analysis, by year
3.6. Porters five forces analysis
3.7. Market dynamics
3.7. Market dynamics
3.7.1. Drivers
3.7.1.1. Technological advancements in DNA sequencing
3.7.1.2. Surge in applications of DNA sequencing
3.7.1.3. Increase in partnerships and collaborations
3.7.1.4. Increase in genome mapping programs
3.7.1.2. Surge in applications of DNA sequencing
3.7.1.3. Increase in partnerships and collaborations
3.7.1.4. Increase in genome mapping programs
3.7.2. Restraints
3.7.2.1. Standardization concerns over DNA sequencing-based diagnostics
3.7.2.2. Dearth of skilled professionals
3.7.2.3. Ethical and legal limitations
3.7.2.2. Dearth of skilled professionals
3.7.2.3. Ethical and legal limitations
3.7.3. Opportunities
3.7.3.1. Lucrative opportunities in emerging markets
3.7.3.2. Cloud computing as a potential data management service
3.7.3.2. Cloud computing as a potential data management service
3.7.4. Impact analyses
CHAPTER 4: DNA SEQUENCING MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Consumables
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Instruments
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Services
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
CHAPTER 5: DNA SEQUENCING MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Biomarker & cancer
5.2.1. Market size and forecast, by region
5.2.2. Market share analysis
5.2.2. Market share analysis
5.3. Diagnostics
5.3.1. Market size and forecast, by region
5.3.2. Market share analysis, by country
5.3.2. Market share analysis, by country
5.4. Reproductive health
5.4.1. Market size and forecast, by region
5.4.2. Market share analysis, by country
5.4.2. Market share analysis, by country
5.5. Personalized medicine
5.5.1. Market size and forecast, by region
5.5.2. Market share analysis, by country
5.5.2. Market share analysis, by country
5.6. Forensics
5.6.1. Market size and forecast, by region
5.6.2. Market share analysis
5.6.2. Market share analysis
5.7. Others
5.7.1. Market size and forecast, by region
5.7.2. Market share analysis
5.7.2. Market share analysis
CHAPTER 6: DNA SEQUENCING MARKET, BY TECHNOLOGY
6.1. Overview
6.1.1. Market size and forecast
6.2. Sequencing by synthesis
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.2.2. Market analysis, by country
6.3. Ion semiconductor sequencing
6.3.1. Market size and forecast, by region
6.3.2. Market share analysis, by country
6.3.2. Market share analysis, by country
6.4. Sequencing by ligation
6.4.1. Market size and forecast, by region
6.4.2. Market share analysis, by country
6.4.2. Market share analysis, by country
6.5. Pyrosequencing
6.5.1. Market size and forecast, by region
6.5.2. Market share analysis, by country
6.5.2. Market share analysis, by country
6.6. Single-molecule real-time sequencing
6.6.1. Market size and forecast, by region
6.6.2. Market share analysis, by country
6.6.2. Market share analysis, by country
6.7. Chain termination technology
6.7.1. Market size and forecast, by region
6.7.2. Market share analysis, by country
6.7.2. Market share analysis, by country
6.8. Nanopore sequencing
6.8.1. Market size and forecast, by region
6.8.2. Market share analysis, by country
6.8.2. Market share analysis, by country
CHAPTER 7: DNA SEQUENCING MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Academic & government research institute
7.2.1. Market size and forecast, by region
7.2.2. Market share analysis, by country
7.2.2. Market share analysis, by country
7.3. Pharmaceutical companies
7.3.1. Market size and forecast, by region
7.3.2. Market share analysis, by country
7.3.2. Market share analysis, by country
7.4. Biotechnology companies
7.4.1. Market size and forecast, by region
7.4.2. Market share analysis
7.4.2. Market share analysis
7.5. Hospital & clinics
7.5.1. Market size and forecast, by region
7.5.2. Market share analysis
7.5.2. Market share analysis
Continue….
About KD Market Insights
KD Market
Insights offers a comprehensive database of syndicated research studies,
customized reports, and consulting services. These reports are created to help
in making smart, instant and crucial decisions based on extensive and in-depth
quantitative information, supported by extensive analysis and industry
insights.
Our dedicated
in-house team ensures the reports satisfy the requirement of the client. We aim
at providing value service to our clients. Our reports are backed by extensive
industry coverage and is made sure to give importance to the specific needs of
our clients. The main idea is to enable our clients to make an informed
decision, by keeping them and ourselves up to date with the latest trends in
the market.
Contact Us
KD Market Insights
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
https://marketreserachtab.blogspot.com/
Comments
Post a Comment